30 May 2010
Washington, DC USA
A new study warns that HIV-infected people in the United States and Canada are not getting treatment early enough.
Researchers conducted a study of 45,000 patients to reach the conclusion.
They analyzed patients’ CD4 cell counts, a critical measure of immune system strength, when these patients first began clinical care for HIV from 1997 to 2007.
Although the median CD4 count at first presentation increased annually over this period, from 256 cells/mm3 to 317 cells/mm3, it remains below the level currently recommended for patients to start antiretroviral therapy, 350 cells/mm3. The median age at which patients first received HIV care increased over the study period from 40 to 43 years of age.
Study author Richard Moore, MD, of Johns Hopkins University School of Medicine in Baltimore said: "The public health implications of our findings are clear: Delayed diagnosis reduces survival, and individuals enter into HIV care with lower CD4 counts than the guidelines for antiretroviral therapy initiation.
"A delay in presentation for treatment not only increases the chance of clinical disease progression but also increases the risk of ongoing transmission."
In an accompanying editorial, Cynthia Gay, MD, of the University of North Carolina at Chapel Hill, agreed: "These findings reveal that despite such compelling data, there is much room for improving our ability to link more HIV-infected individuals with effective treatment prior to immunological deterioration."
The study appears in the June 1, 2010, issue of Clinical
Wednesday, Apr 26th
Last update:05:44:44 AM IST